Analyses of human papillomavirus genotypes and viral loads in anogenital warts

Journal of Medical Virology

Volumn 83, Issue 8, 2011, Pages 1345-1350

  Ball, Siolian L R ^a   Winder, David M ^a   Vaughan, Katie ^a   Hanna, Nashat ^b   Levy, Jonathan ^c   Sterling, Jane C ^a   Stanley, Margaret A ^a   Goon, Peter K C ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

E6 DNA viral loads; E6 mRNA; Genital warts; HPV

Indexed keywords

DNA; MESSENGER RNA;

ARTICLE; CLINICAL ARTICLE; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; MALE; MIXED INFECTION; MORBIDITY; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; VIRUS GENE; VIRUS LOAD; WART VIRUS;

CONDYLOMATA ACUMINATA; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; INCIDENCE; MALE; PAPILLOMAVIRIDAE; PREVALENCE; RNA, MESSENGER; RNA, VIRAL; VIRAL LOAD;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 79959259520     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22111     Document Type: Article

References (33)

1. Aubin F, Prétet JL, Jacquard AC, Saunier M, Carcopino X, Jaroud F, Pradat P, Soubeyrand B, Leocmach Y, Mougin C, Riethmuller D. 2008. Human papillomavirus genotype distribution in external acuminata condylomata: A large French national study (EDiTH IV). Clin Infect Dis 47: 610-615.
2. Brown DR, Schroeder JM, Bryan JT, Stoler MH, Fife KH. 1999. Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 37: 3316-3322.
3. Cattani P, Siddu A, D'Onghia S, Marchetti S, Santangelo R, Vellone VG, Zannoni GF, Fadda G. 2009. RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus. J Clin Microbiol 47: 2136-2141.
4. Chan PKS, Luk ACS, Luk TNM, Lee K-F, Cheung JLK, Ho K-M, Lo K-K. 2009. Distribution of human papillomavirus types in anogenital warts of men. J Clin Virol 44: 111-114.
5. Chrisofos M, Skolarikos A, Lazaris A, Bogris S, Deliveliotis C. 2004. HPV 16/18-associated condyloma acuminatum of the urinary bladder: First international report and review of literature. Int J STD AIDS 15: 836-838.
6. Coleman HM, Connor V, Cheng ZSC, Grey F, Preston CM, Efstathiou S. 2008. Histone modifications associated with herpes simplex virus type 1 genomes during quiescence and following ICP0-mediated de-repression. J Gen Virol 89: 68-77.
7. de Boer MA, Jordanova ES, Kenter GG, Peters AA, Corver WE, Trimbos JB, Fleuren GJ. 2007. High Human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients. Clin Cancer Res 13: 132-138.
8. Doorbar J. 2006. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci 110: 525-541.
9. Fairley CK, Hocking JS, Gurrin LC, Chen MY, Donovan B, Bradshaw C. 2009. Rapid decline in presentations for genital warts after the implementation of a national quadrivalent human papillomavirus vaccination program for young women. Sex Transm Infect 85: 499-502.
10. Giuliano AR, Tortolero-Luna G, Ferrer E, Burchell AN, de Sanjose S, Kjaer SK, Muñoz N, Schiffman M, Bosch FX. 2008. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine 26: K17-K28.
11. Greer CE, Wheeler CM, Ladner MB, Beutner K, Coyne MY, Liang H, Langenberg A, Yen TS, Ralston R. 1995. Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol 33: 2058-2063.
12. Halfon P, Benmoura D, Agostini A, Khiri H, Martineau A, Penaranda G, Blanc B. 2010. Relevance of HPV mRNA detection in a population of ASCUS plus women using the NucliSENS EasyQ® HPV assay. J Clin Virol 47: 177-181.
13. Ho CM, Lee BH, Chang SF, Chien TY, Huang SH, Yan CC, Cheng WF. 2010. Type-specific human papillomavirus oncogene messenger RNA levels correlate with the severity of cervical neoplasia. Int J Cancer 127: 622-632.
14. Keegan H, Mc Inerney J Pilkington L, Grønn P, Silva I, Karlsen F, Bolger N, Logan C, Furuberg L, O'Leary J, Martin C. 2009. Comparison of HPV detection technologies: Hybrid capture 2, PreTect(TM) HPV-Proofer and analysis of HPV DNA viral load in HPV16, HPV18 and HPV33 E6/E7 mRNA positive specimens. J Virol Methods 155: 61-66.
15. Leyva A, Kelley WN. 1974. Measurement of DNA in cultured human cells. Anal Biochem 62: 173-179.
16. Molden T, Kraus I, Skomedal H, Nordstrøm T, Karlsen F. 2007. PreTect(TM) HPV-Proofer: Real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses. J Virol Methods 142: 204-212.
17. Müller EE, Chirwa TF, Lewis DA. 2010. Human papillomavirus (HPV) infection in heterosexual South African men attending sexual health services: Associations between HPV and HIV serostatus. Sex Transm Infect 86: 175-180.
18. Munoz N, Kjaer SK, Sigurdsson K, Iversen O-E, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, Garcia PJ, Ault KA, Garland SM, Leodolter S, Olsson S-E, Tang GWK, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Huh WK, Joura EA, Kurman RJ, Majewski S, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Lupinacci LC, Giacoletti KED, Sings HL, James MK, Hesley TM, Barr E, Haupt RM. 2010. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst 102: 325-339.
19. Nielson CM, Harris RB, Flores R, Abrahamsen M, Papenfuss MR, Dunne EF, Markowitz LE, Giuliano AR. 2009. Multiple-type human papillomavirus infection in male anogenital sites: Prevalence and associated factors. Cancer Epidemiol Biomarkers Prev 18: 1077-1083.
20. Ohl F, Jung M, Radonic A, Sachs M, Loening SA, Jung K. 2006. Identification and validation of suitable endogenous reference genes for gene expression studies of human bladder cancer. J Urol 175: 1915-1920.
21. Potocnik M, Kocjan BJ, Seme K, Poljak M. 2007. Distribution of human papillomavirus (HPV) genotypes in gentital warts from males in Slovenia. Acta Dermatovenerol Alp Panonica Adriat 16: 91-98.
22. Qian Z, Fernald AA, Godley LA, Larson RA, Le Beau MM. 2002. Expression profiling of CD34+ hematopoietic stem/progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia. Proc Natl Acad Sci USA 99: 14925-14930.
23. Radonic A, Thulke S, Bae H-G, Muller M, Siegert W, Nitsche A. 2005. Reference gene selection for quantitative real-time PCR analysis in virus infected cells: SARS corona virus, Yellow fever virus, Human Herpesvirus-6, Camelpox virus and Cytomegalovirus infections. Virol J 2: 7.
24. Sanclemente G, Herrera S, Tyring SK, Rady PL, Zuleta JJ, Correa LA, He Q, Wolff JC. 2007. Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia. J Eur Acad Dermatol 21: 1054-1060.
25. Schlecht HP, Fugelso Dana K Murphy Ryan K, Wagner Katiri T, Doweiko John P, Proper J, Dezube Bruce J, Panther Lori A. 2010. Frequency of occult high grade squamous intraepithelial neoplasia and invasive cancer within anal condylomata in men who have sex with men. Clin Infect Dis 51: 107-110.
26. Schmitt M, Dondog B, Waterboer T, Pawlita M, Tommasino M, Gheit T. 2010. Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay. J Clin Microbiol 48: 143-149.
27. Tucker RA, Unger ER, Holloway BP, Swan DC. 2001. Real-time PCR-based fluorescent assay for quantitation of human papillomavirus types 6, 11, 16, and 18. Mol Diagn 6: 39-47.
28. van Ham MAPC, Bakkers JMJE, Harbers GK, Quint WGV, Massuger LFAG, Melchers WJG. 2005. Comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: Validation of the Roche AMPLICOR HPV Test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders. J Clin Microbiol 43: 2662-2667.
29. van Hamont D, van Ham MAPC, Bakkers JMJE, Massuger LFAG, Melchers WJG. 2006. Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the Roche Linear Array HPV genotyping test. J Clin Microbiol 44: 3122-3129.
30. Viera AJ, Garrett JM. 2005. Understanding interobserver agreement: The Kappa statistic. Fam Med 37: 360-363.
31. Winder DM, Ball SLR, Vaughan K, Hanna N, Woo YL, Fränzer J-T, Sterling JC, Stanley MA, Sudhoff H, Goon PKC. 2009. Sensitive HPV detection in oropharyngeal cancers. BMC Cancer 9: 440.
32. Woo YL, Damay I, Stanley M, Crawford R, Sterling J. 2007. The use of HPV Linear Array Assay for multiple HPV typing on archival frozen tissue and DNA specimens. J Virol Methods 142: 226-230.
33. zur Hausen H. 2002. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2: 342-350.